NDAINJECTIONINJECTABLEPriority Review
Approved
May 1960
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
CARBOCAINE (mepivacaine hydrochloride) by Pfizer is clinical pharmacology mepivacaine hydrochloride is a potent local anesthetic whose effectiveness and safety have been well established in human medicine and dentistry. First approved in 1960.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CARBOCAINE (mepivacaine hydrochloride) is a potent local anesthetic for injection with 2–2.5× the effectiveness of procaine and comparable to lidocaine. It is used in veterinary medicine to produce rapid, prolonged local anesthesia for surgical and diagnostic procedures in animals, particularly equines. The drug works by blocking nerve conduction at the site of injection, with optional vasoconstrictive enhancement via epinephrine addition.
LOE Approaching
As LOE approaches, the brand team is likely consolidating and shifting focus toward lifecycle extensions or transition strategies rather than growth investments.
Mechanism of Action
CLINICAL PHARMACOLOGY Mepivacaine hydrochloride is a potent local anesthetic whose effectiveness and safety have been well established in human medicine and dentistry. Laboratory and clinical studies in animals have confirmed its value in veterinary medicine. Its anesthetic activity is two to two…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CARBOCAINE offers limited career growth potential as a mature, LOE-approaching product with no linked open positions. Roles are primarily defensive—focused on market retention, physician/veterinarian relationship maintenance, and regulatory compliance rather than expansion or innovation.
Worked on CARBOCAINE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.